00981nas a2200121   4500000000100000008004100001260003400042100001300076245010000089856008700189490000800276520057500284       2020                            d  bErasmus UniversityaRotterdam1 aTiwari A00aLeprosy Post-Exposure Prophylaxis with Single-dose Rifampicin. Health economic aspects in India  uhttps://drive.google.com/file/d/11YzOMjNAlk_9rlGNZwudEYtFDCj61B0C/view?usp=sharing0 vPhD3 aThe objective of the thesis was to study the health economic aspects of leprosy prevention through post-exposure prophylaxis (PEP) with single-dose rifampicin (SDR). The Leprosy Post-Exposure Prophylaxis program (LPEP) was a multi-centre study, included India where single-dose rifampicin was administered to the contacts of the leprosy patients. We found that SDR is feasible to implement along with the national leprosy control programme. SDR is cost-effective with an incremental cost of US$ 443 per DALY averted over 25 years. We recommend to scale-up SDR in India.